Provided by Tiger Trade Technology Pte. Ltd.

Immunovant, Inc.

44.37
+0.02000.05%
Post-market: 43.73-0.6392-1.44%19:30 EDT
Volume:846.60K
Turnover:37.69M
Market Cap:9.16B
PE:-15.75
High:45.12
Open:44.85
Low:44.08
Close:44.35
52wk High:45.42
52wk Low:14.47
Shares:206.40M
Float Shares:89.57M
Volume Ratio:0.74
T/O Rate:0.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8178
EPS(LYR):-2.7716
ROE:-80.10%
ROA:-46.73%
PB:12.45
PE(LYR):-16.01

Loading ...

Wells Fargo Sticks to Its Buy Rating for Immunovant (IMVT)

TIPRANKS
·
May 21

U.S. RESEARCH ROUNDUP-Analog Devices, Intuit, Nvidia

Reuters
·
May 21

Immunovant director Atul Pande disposes 6,000 shares for $192,000

Reuters
·
May 21

Top Midday Gainers

MT Newswires Live
·
May 21

Immunovant Stock Surges Despite Disappointing Earnings Miss

Benzinga Earnings
·
May 21

These Stocks Are Today's Movers: Nvidia, Micron, Intel, United, Hasbro, Toll, Immunovant, Analog Devices, and More -- Barrons.com

Dow Jones
·
May 21

This Is Why Immunovant Stock (IMVT) Is Up Today

TIPRANKS
·
May 20

2 Biotech Stocks Are Surging Today Thanks to This Arthritis Drug -- Barrons.com

Dow Jones
·
May 20

Roivant Shares Rise as Focus Intensifies on Key Asset IMVT-1402's Mid-to-Late-Stage Data

Deep News
·
May 20

Stock Track | Immunovant Soars 31.76% Intraday on Promising Rheumatoid Arthritis Drug Trial Data

Stock Track
·
May 20

Immunovant rises 25.9%

TIPRANKS
·
May 20

Immunovant Up Over 25%, on Pace for Largest Percent Increase Since September 2023 -- Data Talk

Dow Jones
·
May 20

Immunovant Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 20

Immunovant Stock Surges 22% on Trial Data. Earnings Are an Afterthought. -- Barrons.com

Dow Jones
·
May 20

Immunovant Shares Surge on Positive Rheumatoid Arthritis Treatment Data

Dow Jones
·
May 20

S&P 500 Futures Rise In Premarket Trading; Immunovant, ImmunityBio Lead

Dow Jones
·
May 20

Immunovant Fiscal Q4 Loss Widens; Shares Up Pre-Bell

MT Newswires Live
·
May 20

Immunovant reports Q4 EPS (73c), consensus (63)

TIPRANKS
·
May 20

Immunovant Shares Jump 16% Premarket After Q4 Results

THOMSON REUTERS
·
May 20

Immunovant Inc Q4 net loss misses on higher R&D costs

Reuters
·
May 20